FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1571636432> ?p ?o ?g. }

• W1571636432 endingPage "2751" @default.
• W1571636432 startingPage "2745" @default.
• W1571636432 abstract "Women who are at increased risk for breast and ovarian cancers, especially BRCA1 and BRCA2 mutation carriers, face a myriad of risk-reduction options, including increased surveillance, chemoprevention, prophylactic oophorectomy, and prophylactic mastectomy. However, little is known about which clinical, demographic, or cancer-related factors are associated with risk-reduction interventions.The authors conducted a retrospective review of records for 554 women who had undergone testing at The University of Texas M. D. Anderson Cancer Center between 2000 and 2006 for deleterious BRCA1 and BRCA2 gene mutations. Data were collected on the risk-reduction interventions these women adopted after they underwent genetic testing. These data were tested for associations with demographic and clinical characteristics.Among the 554 women who underwent genetic testing for BRCA mutation, 78 were found to have a deleterious mutation in the BRCA1 gene, and 54 had a mutation in the BRCA 2 gene. Of the 554 women, 85 underwent prophylactic mastectomy, 30 prophylactic oophorectomy, and 52 both surgeries; 387 women opted for surveillance. Women who had BRCA mutations, a history of breast cancer or ductal carcinoma in situ (DCIS), or previous breast biopsies were more likely to have prophylactic surgery. Women with a family history of ovarian cancer were more likely to undergo prophylactic oophorectomy. Women with a personal history of ovarian cancer or advanced breast cancer were more likely to undergo surveillance only. Women with breast cancer who had had a total mastectomy as part of their prior breast cancer treatment underwent prophylactic mastectomy more frequently than women who either had breast-conserving surgery or no history of breast cancer. In multivariate analysis, only positive BRCA mutation carrier status was associated with having had prophylactic surgery. In addition, breast cancer history was significantly associated with prophylactic mastectomy.Women who were BRCA carriers, women who had a history of breast cancer, DCIS, or breast biopsy, or had a family history of ovarian cancer were more likely to have undergone surgery for cancer risk reduction. Women with ovarian cancer or advanced breast cancer were more likely to have undergone surveillance." @default.
• W1571636432 created "2016-06-24" @default.
• W1571636432 creator A5006802038 @default.
• W1571636432 creator A5008045119 @default.
• W1571636432 creator A5012831310 @default.
• W1571636432 creator A5015127974 @default.
• W1571636432 creator A5048319736 @default.
• W1571636432 creator A5060302560 @default.
• W1571636432 creator A5068491553 @default.
• W1571636432 creator A5076426660 @default.
• W1571636432 creator A5078692182 @default.
• W1571636432 creator A5081496786 @default.
• W1571636432 creator A5083653953 @default.
• W1571636432 date "2006-01-01" @default.
• W1571636432 modified "2023-10-10" @default.
• W1571636432 title "Association between clinical characteristics and risk-reduction interventions in women who underwentBRCA1 andBRCA2 testing" @default.
• W1571636432 cites W1493144403 @default.
• W1571636432 cites W1569033281 @default.
• W1571636432 cites W174839820 @default.
• W1571636432 cites W1776948253 @default.
• W1571636432 cites W1901472791 @default.
• W1571636432 cites W2043853870 @default.
• W1571636432 cites W2045733577 @default.
• W1571636432 cites W2048140101 @default.
• W1571636432 cites W2055908359 @default.
• W1571636432 cites W2076340901 @default.
• W1571636432 cites W2077324625 @default.
• W1571636432 cites W2077992695 @default.
• W1571636432 cites W2098383175 @default.
• W1571636432 cites W2103970959 @default.
• W1571636432 cites W2109764430 @default.
• W1571636432 cites W2110439344 @default.
• W1571636432 cites W2115947304 @default.
• W1571636432 cites W2123915321 @default.
• W1571636432 cites W2128601571 @default.
• W1571636432 cites W2131241397 @default.
• W1571636432 cites W2141647078 @default.
• W1571636432 cites W2144624092 @default.
• W1571636432 cites W2145878689 @default.
• W1571636432 cites W2147058464 @default.
• W1571636432 cites W2150111967 @default.
• W1571636432 cites W2162606219 @default.
• W1571636432 cites W2185443161 @default.
• W1571636432 cites W4293570160 @default.
• W1571636432 doi "https://doi.org/10.1002/cncr.22352" @default.
• W1571636432 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/17109443" @default.
• W1571636432 hasPublicationYear "2006" @default.
• W1571636432 type Work @default.
• W1571636432 sameAs 1571636432 @default.
• W1571636432 citedByCount "67" @default.
• W1571636432 countsByYear W15716364322012 @default.
• W1571636432 countsByYear W15716364322013 @default.
• W1571636432 countsByYear W15716364322014 @default.
• W1571636432 countsByYear W15716364322015 @default.
• W1571636432 countsByYear W15716364322016 @default.
• W1571636432 countsByYear W15716364322017 @default.
• W1571636432 countsByYear W15716364322018 @default.
• W1571636432 countsByYear W15716364322019 @default.
• W1571636432 countsByYear W15716364322020 @default.
• W1571636432 countsByYear W15716364322021 @default.
• W1571636432 countsByYear W15716364322022 @default.
• W1571636432 countsByYear W15716364322023 @default.
• W1571636432 crossrefType "journal-article" @default.
• W1571636432 hasAuthorship W1571636432A5006802038 @default.
• W1571636432 hasAuthorship W1571636432A5008045119 @default.
• W1571636432 hasAuthorship W1571636432A5012831310 @default.
• W1571636432 hasAuthorship W1571636432A5015127974 @default.
• W1571636432 hasAuthorship W1571636432A5048319736 @default.
• W1571636432 hasAuthorship W1571636432A5060302560 @default.
• W1571636432 hasAuthorship W1571636432A5068491553 @default.
• W1571636432 hasAuthorship W1571636432A5076426660 @default.
• W1571636432 hasAuthorship W1571636432A5078692182 @default.
• W1571636432 hasAuthorship W1571636432A5081496786 @default.
• W1571636432 hasAuthorship W1571636432A5083653953 @default.
• W1571636432 hasConcept C121608353 @default.
• W1571636432 hasConcept C126322002 @default.
• W1571636432 hasConcept C131872663 @default.
• W1571636432 hasConcept C141071460 @default.
• W1571636432 hasConcept C143998085 @default.
• W1571636432 hasConcept C2777696064 @default.
• W1571636432 hasConcept C2777757722 @default.
• W1571636432 hasConcept C2779494336 @default.
• W1571636432 hasConcept C2780194787 @default.
• W1571636432 hasConcept C2780427987 @default.
• W1571636432 hasConcept C2780673598 @default.
• W1571636432 hasConcept C2781179581 @default.
• W1571636432 hasConcept C2910039337 @default.
• W1571636432 hasConcept C2910584544 @default.
• W1571636432 hasConcept C29456083 @default.
• W1571636432 hasConcept C530470458 @default.
• W1571636432 hasConcept C71924100 @default.
• W1571636432 hasConceptScore W1571636432C121608353 @default.
• W1571636432 hasConceptScore W1571636432C126322002 @default.
• W1571636432 hasConceptScore W1571636432C131872663 @default.
• W1571636432 hasConceptScore W1571636432C141071460 @default.
• W1571636432 hasConceptScore W1571636432C143998085 @default.
• W1571636432 hasConceptScore W1571636432C2777696064 @default.
• W1571636432 hasConceptScore W1571636432C2777757722 @default.

• next